Trials / Completed
CompletedNCT00174226
Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
Eight-Week, Double-Blind, 3-Arm Parallel, Placebo-Controlled, Randomized Efficacy And Safety Trial Of Atomoxetine, Atomoxetine Plus Buspirone, And Placebo In Adults With Attention Deficit Hyperactivity Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 241 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atomoxetine | |
| DRUG | Buspirone |
Timeline
- Start date
- 2004-11-01
- Completion
- 2006-01-01
- First posted
- 2005-09-15
- Last updated
- 2008-07-15
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00174226. Inclusion in this directory is not an endorsement.